4:13 PM ET
8-K
Leadership Change
Avalyn Pharma Leadership Change
Avalyn Pharma Inc. appointed Robert Meyer, M.D. to its Board of Directors as a Class II director, effective September 15, 2026. Dr. Meyer, a former FDA director and Merck executive, brings extensive regulatory and clinical experience to the board. He will receive an annual cash retainer of $40,000 and an initial grant of options to purchase 31,182 shares of common stock.
- Counterparty
- Robert Meyer, M.D.